Novacyt S.A.

As of December 31, 2024, Novacyt S.A. carries a market capitalization of 42.90M, placing it among publicly traded companies globally. Its enterprise value stands at 20.44M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Novacyt S.A.'s next confirmed earnings release is scheduled for April 29, 2027.

As of December 31, 2024, Novacyt S.A. has 70.63M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Novacyt S.A. maintains a current ratio of 6.33, meaning it holds 6.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Novacyt S.A.'s stock has declined approximately 4.26% over the past 52 weeks. The 50-day moving average sits at 0.50, while the 200-day moving average is 0.45.

As of December 31, 2024, Novacyt S.A. holds 36.81M in cash and equivalents against 14.35M in total debt, resulting in a net debt position of -36.80M. Total book value stands at 57.86M, with working capital of 40.07M providing operational flexibility.